The tip was the 2017 in the link you’ve posted. That deal happened 2 years before the bankruptcy. It is likely the licensing deal passed on to the new owners of Ceplene.
Save some time, just Google up what Chapter 7 is, and you’ll find there is zero “hope” for Immune and its shareholders.